Advaxis Seeks FDA Approval to Begin Phase 1 Trial of its ADXS-504 Immunotherapy for Prostate Cancer Prostate Cancer Research, ImmunotherapyVipul PatelAugust 4, 2020Immunotherapy for Prostate Cancer, prostate cancer treatments, Research
